Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 18.7

(3.03%)

Eps Summary of Welgene Biotech Co.,Ltd.

  • Welgene Biotech Co.,Ltd.'s latest annual eps in 2023 was -0.11 TWD , down -126.83% from previous year.
  • Welgene Biotech Co.,Ltd.'s latest quarterly eps in 2024 Q2 was -0.02 TWD , up 90.54% from previous quarter.
  • Welgene Biotech Co.,Ltd. reported an annual eps of 0.41 TWD in 2022, down -30.51% from previous year.
  • Welgene Biotech Co.,Ltd. reported an annual eps of 0.59 TWD in 2021, down -59.03% from previous year.
  • Welgene Biotech Co.,Ltd. reported a quarterly eps of -0.24 TWD for 2024 Q1, down -100.0% from previous quarter.
  • Welgene Biotech Co.,Ltd. reported a quarterly eps of -0.12 TWD for 2023 Q4, down -225.2% from previous quarter.

Annual Eps Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Eps of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year Eps Eps Growth
2023 -0.11 TWD -126.83%
2022 0.41 TWD -30.51%
2021 0.59 TWD -59.03%
2020 1.44 TWD -3.36%
2019 1.49 TWD 8.76%
2018 1.37 TWD 20.18%
2017 1.14 TWD 470.0%
2016 0.20 TWD -84.96%
2015 1.33 TWD -31.09%
2014 1.93 TWD 0.0%

Peer Eps Comparison of Welgene Biotech Co.,Ltd.

Name Eps Eps Difference
BIONET Corp. 1.55 TWD 107.097%
DIVA Laboratories, Ltd. 1.25 TWD 108.8%
Genetics Generation Advancement Corp. 1.07 TWD 110.28%
Puriblood Medical Co., Ltd. -3.63 TWD 96.97%
TFBS Bioscience Inc. 0.17 TWD 164.706%